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Background: Hydroxycinnamates (HCs) are mainly produced in plants. Caffeic acid (CA), p-coumaric acid (PA),
ferulic acid (FA) and sinapic acid (SA) are members of the HC family. The consumption of HC by human might
prevent cardiovascular disease and some types of cancer. The solubility of HCs is increased through thioester
conjugation to various compounds such as quinic acid, shikimic acid, malic acid, anthranilic acid, and glycerol.
Although hydroxycinnamate conjugates can be obtained from diverse plant sources such as coffee, tomato, potato,
apple, and sweet potato, some parts of the world have limited availability to these compounds. Thus, there is
growing interest in producing HC conjugates as nutraceutical supplements.
Results: Hydroxycinnamoyl transferases (HCTs) including hydroxycinnamate-CoA shikimate transferase (HST) and
hydroxycinnamate-CoA quinate transferase (HQT) were co-expressed with 4-coumarateCoA:ligase (4CL) in
Escherichia coli cultured in media supplemented with HCs. Two hydroxycinnamoyl conjugates, p-coumaroyl
shikimates and chlorogenic acid, were thereby synthesized. Total 29.1 mg/L of four different p-coumaroyl shikimates
(3-p-coumaroyl shikimate, 4-p-coumaroyl shikimate, 3,4-di-p-coumaroyl shikimate, 3,5-di-p-coumaroyl shikimate, and
4,5-di-p-coumaroyl shikimate) was obtained and 16 mg/L of chlorogenic acid was synthesized in the wild type
E. coli strain. To increase the concentration of endogenous acceptor substrates such as shikimate and quinate, the
shikimate pathway in E. coli was engineered. A E. coli aroL and aroK gene were mutated and the resulting mutants
were used for the production of p-coumaroyl shikimate. An E. coli aroD mutant was used for the production of
chlorogenic acid. We also optimized the vector and cell concentration optimization.
Conclusions: To produce p-coumaroyl-shikimates and chlorogenic acid in E. coli, several E. coli mutants (an aroD
mutant for chlorogenic acid production; an aroL, aroK, and aroKL mutant for p-coumaroyl-shikimates production)
were made and each mutant was tested using an optimized construct. Using this strategy, we produced 235 mg/L
of p-coumaroyl-shikimates and 450 mg/L of chlorogenic acid.
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Hydroxycinnamate-CoA shikimate transferaseBackground
Hydroxycinnamates (HCs) such as caffeic acid (CA),
p-coumaric acid (PA), ferulic acid (FA) and sinapic acid
(SA) are mainly produced in plants. Because HCs are
anti-oxidants that can scavenge free radicals, it has been
suggested that consumption of HCs might prevent
cardiovascular disease and some types of cancer. In* Correspondence: jhahn@konkuk.ac.kr
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reproduction in any medium, provided the oraddition, several biological functions of HCs have been
described, such as protection against side effects of che-
motheraphy and anti-osteoclast activity [1].
In plants, HCs are usually conjugated with other com-
pounds such as quinic acid, shikimic acid, malic acid,
anthranilic acid, and glycerol [2]. Chlorogenic acid, the
conjugate of CA and quinate, is abundant in coffee,
fruits, and vegetables, and is the primary source of CA
in the human diet [3]. For regular consumers of coffee
in Western countries, the major dietary phenolics are
chlorogenic acids [4].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ester conjugation to various compounds. Although
there is growing evidence for their beneficial health
effects, the fruits and vegetables that contain high
levels of HC conjugates are of limited availability in
some parts of the world. Thus, there is growing
interest in producing HC conjugates as nutraceutical
supplements. The primary strategy for obtaining di-
verse phytochemicals is by extracting them from
plants. However, this approach faces several obstacles
such as a limited availability of plant materials and
high costs of extraction and purification. Alterna-
tively, they can be produced in microorganisms. Phy-
tochemicals such as flavonoids and stilbenes have
been produced using microorganisms such as Escher-
ichia coli and Saccharomyces cerevisiae [5-7].
Biosynthesis of HC conjugates is mediated by
hydroxycinnamoyl transferases (HCTs), which use
the coenzyme A thioester of HCs as a donor and
various compounds such as quinate, and shikimate
as HC acceptors. The formation of coenzyme A
thioester with HC is catalyzed by 4-coumaric acid:
CoA ligase (4-CL) [8]. Thus, genes encoding 4-CL
and HCT, are essential for producing HC conjugates
from HC. HCTs from several plants have been char-
acterized [8-12]. HCTs show specificity for not only
the acyl group donor but also the acyl group ac-
ceptor. When the acyl group acceptors are shikimate
and quinate, the resulting conjugates are p-coumar-
oyl-O-shikimate and chlorogenic acid, respectively
[13,14].
E. coli is a good system for producing plant
secondary metabolites including phytochemicals pro-
duced through the phenylpropanoid pathway [15]. We
attempted to produce HC conjugates using E. coli.
Shikimate and 3-dehydroquinate, which are acyl group
acceptors for hydroxycinnamate-CoA shikimate trans-
ferases (HST) and hydroxycinnamate-CoA quinate
transferases (HQT), respectively, can be synthesized
through the shikimate pathway of E. coli [16,17].
Thus, it should be possible to alter the shikimate
pathway to increase the concentrations of shikimate
and quinate. However, the acyl donor (PA or CA) is a
unique product of plants [18]. In order to produce
HCs in E. coli, coexpression of several genes in E. coli
is necessary, which leads to metabolic load. Therefore
addition of exogenous HCs may circumvent this
problem. In this report, we introduced either HST
and 4CL (for the production of CA-shikimate), or
HQT and 4CL (for the production of chlorogenic
acid) into E. coli mutants that accumulate either
shikimate or 3-hydroquinate. When the engineered
cells were fed exogenous HCs, a high yield of HC-
shikimate and HC-quinate were obtained.Results
Construction and selection of the optimum expression
vector for the synthesis of HC-shikimate
HC-shikimate was synthesized from HC-CoA and shiki-
mate using HST (Figure 1). Two genes, HST from
Nicotiana tabacum (NtHST) and 4CL from Oryza sativa
(Os4CL), were subcloned into an E. coli expression vec-
tor. Os4CL converts the HCs into the corresponding
HC-CoAs. Os4CL has a better catalytic efficiency than
other 4CLs [19]. NtHST uses HC-CoAs such as p-cou-
maroyl-CoA, caffeoyl-CoA, and feruloyl-CoA as acyl
donors and shikimate as an acyl acceptor to produce
HC-shikimate. NtHST was the first characterized HST
and only a few number of HST has been biochemically
characterized. NtHST also uses quinate as an acyl ac-
ceptor [9]. Both genes (NtHST and Os4CL) were sub-
cloned into three different E. coli expression vectors,
each of which has a different copy number in E. coli.
Each construct (pA-NtHST-Os4CL, pC-NtHST-Os4CL,
or pE-NtHST-Os4CL; see Table 1) was transformed into
E. coli BL21(DE3) cells, and tested for its ability to pro-
duce HC-shikimate when incubated with exogenous PA.
As a control, the empty vector was transformed into
E. coli. HCs including PA can enter into E. coli via the 4-
hydroxyphenylacetate permease (HpaX transporter) [20]
and small phenolic compounds can be exported from
E. coli into the culture medium. The transformant har-
boring pC-NtHST-Os4CL produced the highest concen-
tration of HC-shikimate derivatives (29.1 mg/L), whereas
the titers of HC-shikimate derivatives produced by
the transformants harboring pA-NtHST-Os4CL or pE-
NtHST-Os4CL were 24.4 and 27.4 mg/L, respectively.
However, only PA was observed in the transformant har-
boring the empty vector. According to ANOVA test, a
significant difference in PA-shikimates production at
P=0.01 was shown between pC-NtHST-Os4CL and
pA-NtHST-Os4CL or between pE-NtHST-Os4CL and
pA-NtHST-Os4CL, but not between pC-NtHST-Os4CL
and pE-NtHST-Os4CL. The construct present in the
pCDF vector (pC-NtHST-Os4CL) was used in further
studies because this construct has a lower copy number
than pE-NtHST-Os4CL. Therefore, pC-NtHST-Os4CL is
expected to impose a lower metabolic load on E. coli.
Although each vector exhibited varying biotransform-
ation efficiencies, they all had the same reaction profiles.
As shown in Figure 2, four new peaks appeared (P1 -
P4). The molecular mass of P1 was 320.2 Da, indicating
that one molecule of PA was attached to shikimate prob-
ably at the 5'-hydroxyl group of shikimate according to
enzymatic studies [9,10]. In contrast, the molecular mass
of the other three reaction products (P2 - P4) was 466.2
Da. Because the molecular mass of PA is 164 Da and
that of shikimate is 174 Da, the three reaction products
must be conjugates of two PA molecules and one
Figure 1 Schematic diagram showing the shikimate pathway of Escherichia coli and production of hydroxycinnamoyl quinate and
hydroxycinnamoyl shikimate in E. coli.
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commercially available and the structures of the reaction
products was determined using nuclear magnetic reson-
ance spectroscopy (NMR). By the help of the HMBC
and HMQC experiments (Additional file 1: Figure S1,
S2), 14 13C peaks were determined, so that P1 was con-
sidered to be a conjugate of PA and shikimate. Even this
structure contains 16 carbons, two set symmetric car-
bons of PA provide only two carbon peaks. Based on the
HMBC spectrum (Additional file 1: Figure S1), the carb-
oxyl group of PA was connected to the hydroxyl group
of shikimate. Three isomers, the carboxyl group of PA
connected to 3"-OH or 4"-OH or 5"-OH of shikimate,
were possible. In the current NMR experiments, we
could not determine the connected position. The name
of the product P1 is (E)-3,4-dihydroxy-5-(3-(4-hydroxy-
phenyl)acryloyloxy)cyclohex-1-enecarboxylic acid where
the bold number 5 could be switched with 3 or 4.
Based on the molecular masses of P2, P3, and P4
(Figure 2C), they contained two PAs and one shikimate.
Two PAs can be connected to 3"-OH or 4"-OH or 5"-
OH of SA, so that there can be three isomers, i.e. 3"-
OH/4"-OH, 3"-OH/5"-OH, or 4"-OH/5"-OH. We could
not determine which produce was which isomer. By
comparison to a previous report [21], P3 and P4 are
likely to be 3,5-di-p-coumaroyl shikimate and 4,5-di-p-cou-
maroyl shikimate, respectively. The remaining peak, P2 is
therefore likely to be 3,4-di-p-coumaroyl shikimate.Using E. coli harboring pC-NtHST-Os4CL, we deter-
mined the best acyl donor among CA, PA, and FA. In a
previous study, recombinant NtHST protein most effi-
ciently used caffeoyl-CoA as an acyl donor [9]. In this
study, 1 mM of each HC was added to the same number
of cells, and biotransformation was performed for 6 h.
PA was the most effective acyl donor, producing 23.9
mg/L of p-coumaroyl shikimate. The amounts of feruloyl
shikimate and caffeoyl shikimate produced were 3.8
mg/L, and 3.1 mg/L, respectively. Taken together, these
results indicate that the highest amount of HC-
shikimate was obtained with pC-NtHST-Os4CL as the
construct and PA as the substrate.
Engineering E. coli to increase production of PA-shikimate
conjugates
Because PA was added to the E. coli culture as an acyl
donor, it was not a limiting factor for the production of
PA-shikimate conjugates. However, E. coli uses endogen-
ous shikimate as an acyl group acceptor. Thus, limiting
shikimate availability would cause a bottleneck in the
production of PA-shikimate conjugate. Previous studies
showed that deletion of aroK and/or aroL in E. coli
results in increased shikimate accumulation [22-24]. We
created an E. coli aroL deletion mutant (BaroL), an aroK
deletion mutant (BaroK) and an aroK/aroL double mu-
tant (BaroKL) by gene replacement. pC-NtHST-Os4CL
was transformed into each mutant and into wild type.
Table 1 Plasmids, Escherichia coli strains, and primers used in this study
Plasmids or E. coli strains or Primers Relevant properties or genetic marker Source or reference
Plasmids
pCYCDuet P15A ori, Cmr Novagen
pCDFDuet CloDE13 ori, Strr Novagen
pETDuet f1 ori, Ampr Novagen
pA-NtHST-Os4CL pACYCDDuet carrying NtHST from N. tobacco and 4CL from O. sativa This study
pC-NtHST-Os4CL pCDFDuet carrying NtHST from N. tobacco and 4CL from O. sativa This study
pE-NtHST-Os4CL pETDuet carrying NtHST from N. tobacco and 4CL from O. sativa This study
pC-NtHQT-Os4CL pCDFDuet carrying NtHQT from N. tobacco and 4CL from O. sativa This study
pA-EcydiB pACYC carrying ydiB from E. coli This study
Strains
BL21 (DE3) F- ompT hsdSB(rB- mB-) gal dcm lon (DE3) Novagen
B-100 BaroD carrying pCDF-Duet This study
B-101 BaroD carrying pC-NtHQT-Os4CL This study
B-102 BaroD carrying pC-NtHQT-Os4CL and pA-EcydiB This study
BaroD BL21(DE3) ΔaroD::FRT-kanR-FRT This study
BaroK BL21(DE3) ΔaroK::FRT-kanR-FRT This study
BaroL BL21(DE3) ΔaroL::FRT-kanR-FRT This study
BaroKL BL21(DE3) ΔaroK::FRT ΔaroL::FRT-kanR-FRT This study
Primers
NtHST-F1 AACATATGAAGATCGAAGTGAAAGAAT (NdeI site is underlined)
NtHST-R2 AACTCGAGTCAAAAGTCATACAAGAACTTC (XhoI site is underlined)
NtHQT-F AAGATATCCATGGGAAGTGAAAAAATGATGA (EcoRV site is underlined)
NtHQT-R AAGGTACCTCAAAATTCATACAAATACTT (KpnI site is underlined)
ydiB-F ATGAATTCGATGGATGTTACCGCAAAATAC (EcoRI site is underlined)









aroK or aroL check-R taatacgactcactatagggctc
aroD-check-F ggcaaggggctgaacagttc
aroD-check-R gggaggatattcccgccgaa
1F means forward primer.
2R means reverse primer.
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235 mg/L), which is approximately 15-fold higher than
BL21 (16 mg/L). BaroKL and BaroK produced 228 mg/L
and 171 mg/L of PA-shikimates, respectively (Figure 3).
According to ANOVA test, PA-shikimates production
was significantly different at P=0.01 level among BL21,BaroK, and BaroL. However, there was no difference be-
tween BaroL and BaroKL at this level of significance.
Next, production of PA-shikimate was optimized using
BaroL harboring pC-NtHST-Os4CL. The optimum cell
concentration was determined by varying the cell con-
centration from OD600 1 to 5 in the presence of 1 mM
Figure 2 High performance liquid chromatography analysis of biotransformation of p-coumaric acid in BL21 (DE3) harboring Os4CL
and NtHST. A, p-coumaric acid (S1); B, reaction products of p-coumaric acid (P1 - P4); C, mass spectrometry (MS) data for the four reaction
products. The mass spectrometer was operated in negative mode. The molecular masses of p-coumaric acid and shikimic acid are 164 Da and
174 Da, respectively.
Kim et al. Microbial Cell Factories 2013, 12:15 Page 5 of 11
http://www.microbialcellfactories.com/content/12/1/15PA. Production of PA-shikimate peaked at an OD600 of
3, at which cell concentration the yield of PA-shikimate
was approximately 235 mg/L. At OD600 = 1, or 2, the
yield was approximately 94 mg/L, and 169 mg/L, re-
spectively. Above OD600 = 3, the production of PA-
shikimate decreased and was approximately 188 or 103.7
mg/L at OD600 = 4 or 5, respectively.
Using BaroL harboring pC-NtHST-Os4CL at a cell
concentration of OD600 3, we monitored the production
of HC-shikimate over 12 h. The maximum amount of
di-p-coumaroyl shikimates was produced at 8 h (134
mg/L 3,5-di-p-coumaroyl shikimate, 70 mg/L 4,5-di-p-
coumaroyl shikimate, 8 mg/L of 3,4-di-p-coumaroyl
shikimate, and 23 mg/L of 5-p-coumaroyl shikimate).
Therefore, a total of 235 mg/L of PA-shikimates was
produced. At 8 h, the amount of 4,5-di-p-coumaroylshikimate and 3,5-di-p-coumaroyl shikimate was
reduced, but the amount of 5-p-coumaroyl shikimate
reached a maximum (Figure 4). It seems that 5-p-cou-
maroyl shikimate was immediately converted to either
3,5-di-p-coumaroyl shikimate or 4,5-di-p-coumaroyl shi-
kimate before 8 h.
Production of HC-quinate in E. coli
We used an acyltransferase that is specific for quinate to
produce HC-quinate. Hydroxycinnamoyl-CoA quinate
transferase from N. tobacco (NtHQT) was shown to be
more specific for quinate than for shikimate [9,25].
Os4CL mediates formation of coenzyme A thioester
with HC. To produce HC-quinate in E. coli, two genes,
NtHQT and Os4CL, were subcloned into an E. coli ex-
pression vector. The resulting construct, pC-NTHQT-
Figure 3 Production of hydroxycinnamic shikimates in different
E. coli strains. Product 1 contains one molecule of
hydroxycinnamate attached to shikimate, while products 2–4
contain two molecules of hydroxycinnamate attached to shikimate.
Error bars indicate mean values ± SD from three independent
experiments. Product 1 is 3 or 4-p-coumaroyl shikimate; The
structures of product 2, product 3, and product 4 are likely to be
3,4-di-p-coumaroyl 3,5-di-p-coumaroyl shikimate, and
4,5-di-p-coumaroyl shikimate, respectively.
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formant was used for biotransformation of CA. How-
ever, no reaction product was detectable. The amount of
quinate or dehydroquinate in E. coli may not be high
enough to drive the production of chlorogenic acid.
Therefore, we created strain BaroD, which should accu-
mulate higher levels of dehydroquinate and/or quinate,Figure 4 Production of hydroxycinnamic shikimates by biotransforma
mean values ± SD from three independent experiments.in order to overcome this potential limitation. The strain
BaroD was used as a host for pC-NTHQT-Os4CL and
the resulting transformant was called B-101 (Table 1).
As control, empty pCDFDuet was transformed into the
strain BaroD and this transformant was called B-100
(Table 1). Each transformant was used for biotransform-
ation of CA. The culture medium of B100 became a
brown color after 8 h. Analysis of the reaction mixture
using HPLC after 8 h incubation showed a trace level of
caffeic acid. In addition, no detectable new product was
observed. The decrease of caffeic acid during biotrans-
formation is associated with the formation of O-quinone
and its polyaromatic derivatives [26]. However, analysis
of the biotransformation mixture from strain B-101
showed a new peak (Figure 5C) and the color of the
culture medium did not change. Once caffeic acid is
converted into another compound, it cannot polymerize
and therefore the color of the culture medium does not
change. The molecular mass of the product was 352 Da,
which was 2 Da less than the predicted molecular mass
of the thioester of quinate and CA (Figure 5C and E).
Based on the molecular weight of the reaction product
and the known intermediates of the E. coli shikimate
pathway, it is like that 3-dehydroquinate and not quinate
was attached to CA. NtHQT utilized 3-dehydroquinate
as an acceptor and caffeoyl-CoA as a donor to make caf-
feoyl-3-dehydroquinate. Expression of ydiB from E. coli,
which converts dehydroquinate into quinate, also
increased the production of HC ester yield because
NtHQT was likely to have higher affinity for quinate
than for dehydroquinate as acyl group acceptor.
The protein product of ydiB converts 3-dehydroquinate
into quinate [27]. ydiB was overexpressed in E. coli straintion using BaroL harboring pC-NtHST-Os4CL. Error bars indicate
Figure 5 Production of chlorogenic acid in E. coli. A, caffeic acid (S1); B, chlorogenic acid (S2); C, reaction product of caffeic acid obtained
from strain B-101; D, reaction product of caffeic acid obtained from strain B-102; E, MS/MS profile of P1; F, MS/MS profile of P2.
Kim et al. Microbial Cell Factories 2013, 12:15 Page 7 of 11
http://www.microbialcellfactories.com/content/12/1/15B-101 to make strain B-102. Biotransformation of CA by
strain B-102 resulted in a new product with an identical
HPLC retention time and molecular mass (354 Da) as
chlorogenic acid (Figure 5D, F). The MS/MS spectrum of
the reaction product matched authentic chlorogenic acid.
This indicates that ydiB converts 3-dehydroquinate into
quinate, which was then utilized for the production of
chlorogenic acid.
PA and FA were also tested as acyl-group donors. CA
was the best acyl-group donor followed by PA and FA.
After 24 h, the amounts of caffeoyl-quinate, p-coumar-
oyl-quinate, and feruloyl-quinate were 450 mg/L, 323.7
mg/L, and 216 mg/L, respectively.
The production of chlorogenic acid was monitored fur-
ther in strain B-102. After induction, 1.1, 1.3, 1.5, 1.7, or
2.0 mM CA was added to the culture. After 24 h, almost
all of the CA was converted into chlorogenic acid in the
reaction mixtures supplied with 1.1, 1.3, or 1.5 mM of CA.
However, at a concentration of 1.7 or 2.0 mM, some CAremained in the mixture, and even after a longer incuba-
tion time, the remaining caffeic acid was not converted
into chlorogenic acid. However, the color of the mixture
became dark brown due to the oxidation/polymerization of
CA. Therefore, we monitored chlorogenic acid production
at a CA concentration of 1.5 mM. As shown in Figure 6,
production of chlorogenic acid continued to increase until
24 h, while the CA content decreased. Approximately 450
mg/L of chlorogenic acid was produced at 24 h.
Discussion
Anthocyanins, flavonoids, stilbene, and other com-
pounds of plant origins have been biologically synthe-
sized using engineered E. coli strains [7,15]. Most of
these efforts involved introduction of new genes with
high activity into E. coli. In addition, cofactor supple-
mentation and reducing equivalents have been enhanced
to produce natural compounds using engineered E. coli
[6,28]. The goal of this study was to produce PA-
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neered the shikimate pathway of E. coli to accumulate
the acyl group acceptors, shikimate and quinate, which
led to the increased production of PA-shikimates and
chlorogenic acid.
During biotransformation, two PA molecules are
attached to shikimate, whereas only one molecule of CA
is attached to quinate. In plants, one molecule of CA is
bound to one molecule of shikimate. However, diverse
HC-quinate conjugates, including those in which two or
three identical HCs are bound to quinate, and two or
three different HCs are bound to quinate, were found in
coffee (Coffea robusta) and sweet potato (Ipomonea
batatas) [21,29]. In these plants, the mono-esters are
present as major components whereas di- and tri-esters
are present as minor components. NtHST and NtHQT
may have different enzymatic properties from HCTs
from coffee or sweet potato because di-p-coumaroyl ski-
mates and cholorgenic acid were synthesized using
NtHST and NtHQT. One possible scenario is that the
substrate binding pocket of NtHQT may be narrower
than that of NtHST. Thus, HC-quinate may not fit into
the substrate binding pocket of NtHQT for the second
round of acyl transfer reaction. Longer incubation of the
recombinant NtHST enzyme with PA-CoA and shiki-
mate resulted in the production of di-PA-shikimate (data
not shown). The production of di-PA-shikimate was
also observed with HST from Populus euramericana
[13]. Using the properties of NtHST, diverse HC-
shikimate conjugates could possibly be obtained and
feeding of different concentrations of various HCs into
the E. coli culture medium may result in production of
various forms of HC-shikimate conjugates. Any bio-
logical activity including anti-oxidant activity of di-PA-
shikimate compared to PA-shikimate has not beenFigure 6 Production of chlorogenic acid using the E. coli strain B-106tested. However, 8-O-4-diferulic acid showed better
antioxidant activity than ferulic acid [30].
p-Coumaric acid can be synthesized from tyrosine by
the action of tyrosine ammonia lyase (TAL). Therefore,
synthesis of p-coumaroyl-shikimate or chlorogenic acid
from glucose might be possible if a gene econding TAL
were expressed into E. coli harboring NtHST and Os4CL
or into E. coli harboring NtHQT, Os4CL, ydiB, and Sam5
(Sam5 converts p-coumaric acid into caffeic acid [31]),
respectively. However, it is expected that only a tiny
amount of reaction product would be produced from
glucose in a wild type strain because quinate and shiki-
mate are not accumulated in the wild type E. coli. Use of
strain BaroD or BaroL is not also feasible because tyro-
sine is not synthesized in these strains. Thus, supple-
mentation with either caffeic acid or tyrosine is needed
to synthesize p-coumaroyl-shikimate or chlorogenic acid
in E. coli.
Wild type E. coli expressing NtHQT and Os4CL did
not produce detectable amounts of chlorogenic acid or
caffeoyl-dehydroquinate after CA supplementation. In
the wild type, dehydroquinate may have been rapidly
converted into another downstream compound of the
shikimate pathway instead of accumulating. Moreover,
the expression level of ydiB, which converts dehydroqui-
nate into quinate, was low. Only a small amount of
quinate or dehydroquinate will be expected to be present
in the cell in the absence of overexpression of ydiB [32].
ydiB and aroE mediate the conversion reaction not only
from dehydroquinate to quinate but also from dehy-
droshikimate to shikimate. However, aroE prefers dehy-
droshikimate to dehydroquinate [22], whereas ydiB has
nearly the same catalytic efficiency for dehydroshikimate
and dehydroquinate [27,33]. Recent studies have shown
that overexpression of ydiB does not increase shikimate,.
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dehydroshikimate to shikimate [32]. Therefore, we
overexpressed ydiB to produce chlorogenic acid. In
addition, strains BaroK, BaroL, and BaroKL expressing
pC-NtHQT-Os4CL that were supplemented with CA
produced chlorogenic acid only when ydiB was overex-
pressed (data not shown). This indicated that these
mutants accumulate shikimate pathway intermediates
such as dehydroquinate, dehydroshikimate and shiki-
mate. These intermediates are converted into quiniate
by ydiB.
Conclusions
To produce the HC-conjugates in E. coli, several E. coli
mutants including aroD, aroK, aroL, and aroK/L
mutants were made and each mutant was tested using
an optimized construct. For the production of HC-shiki-
mates, an E. coli aroL mutant (B-aroL) was best and we
produced 235 mg/L of HC-shikimates using B-aroL
expressing NtHST and Os4CL, which is approximately
15-fold higher than wild type E. coli BL21 (16 mg/L).
The wild type E. coli expressing NtHQT and Os4CL did
not produce any detectable chlorogenic acid. By using E.
coli aroD mutant (strain B-101), which accumulated
3-dehydroquinate, caffeoyl-3-dehydroquinate instead of
chlorogenic acid, was synthesized. However, by expres-
sing ydiB gene in strain B-101, which converted 3-
dehyroquinate to quinate, chlorogenic acid production
was dramatically increased up to 450 mg/L.
Materials and methods
Strains and reagents
The E. coli strains used in this study are listed in Table 1.
E. coli BL21 (DE3) cells were used for recombinant pro-
tein production. E. coli DH5α cells were used for plas-
mid cloning. All restriction enzymes and T4 DNA ligase
were purchased from Takara (Shiga, Japan). Polymerase
chain reaction (PCR) amplification was performed using
Hotstart Taq DNA polymerase (Qiagen, Hilden Germany).
Reverse transcription was performed using Omniscript
reverse transcriptase (Qiagen). E. coli was cultured in
Luria-Bertani (LB) or M9 medium (plus 2% glucose)
containing 50 μg/mL antibiotics, when necessary. E. coli ex-
pression vectors were purchased from Novagen (Madison,
WI, USA).
Construction of E. coli expression vector
The genes for hydroxycinnamate-CoA shikimate trans-
ferase (NtHST) [9] and hydroxycinnamate-CoA quinate
transferase (NtHQT) from tobacco (N. tabacum) [26]
were cloned using reverse-transcription polymerase
chain reaction (RT-PCR). Total RNA was isolated from
the leaves of one-month-old tobacco using Plant Total
RNA Isolation Kit (Qiagen), and cDNA was synthesizedusing Omniscript reverse transcriptase (Qiagen) and
oligo dT as a primer. PCR was carried out using primers
designed on the basis of the published sequences
(GenBank accession AJ507825 for NtHST and AJ582651
for NtHQT). The primers were listed in Table 1. The
Os4CL gene, which was cloned and characterized previ-
ously from rice [19], was subcloned into the BamHI/
NotI sites of pACYCDuet, pCDFDuet, and pETDuet vec-
tors (EMD Chemicals, Gibbstown, NJ, USA), and then
the resulting NtHST PCR product was subcloned into a
second cloning site, the NdeI/XhoI site of each vector.
The NtHQT PCR product was subcloned into the
EcoRV/KpnI site of pCDFDuet, which contains Os4CL
at NdeI/XhoI site. The resulting constructs are listed
in Table 1.
Deletion of the aroL and aroK genes in E. coli BL21
(DE3) was accomplished using the Quick and Easy
Conditional Knockout Kit (Gene Bridges, Heidelberg,
Germany). Briefly, the aroL gene or the aroK gene of E.
coli BL21 (DE3) was replaced by the ΔaroL FRT-PGK-
gb2-neo-FRT cassette or the ΔaroK FRT-PGK-gb2-neo-
FRT cassette, respectively [34]. Deletion mutants were
selected in Luria-Bertani (LB) medium containing 50 μg/
mL kanamycin. Deletion of aroL or aroK was confirmed
using PCR. The strains deleted in aroL or aroK were
named BaroL and BaroK, respectively (Table 1). ΔaroL
and ΔaroK double mutant (strain BaroKL in Table 1)
was constructed using strain BaroL. The kanamycin cas-
sette was removed in ΔaroL using an FLP expression
plasmid, which removes the kanamycin selection marker
from the chromosome. Removal of the kanamycin cas-
sette was confirmed by PCR. Using ΔaroL as a host, the
aroK gene was replaced by the ΔaroK FRT-PGK-gb2-
neo-FRT cassette. The primer sequences for the aroD,
aroK, and aroL deletion are shown in Table 1.
Shikimate/quinate dehydrogenase gene, ydiB was cloned
using E. coli BL21 (DE3) genomic DNA as a template.
Primers were designed based on the published sequence
(NC_000913.2) and the sequences of primers were listed in
Table 1. The PCR product was digested with EcoRI/NotI
and subcloned into the corresponding site of pCDF-Duet1.
The resulting constructs were confirmed by sequencing.
Production of HC-shikimate conjugate in E. coli
Each construct was transformed into E. coli BL21 (DE3)
strain or BaroL strain using electroporation with the
BioRad MicroPulser Electroporation Apparatus (BioRad,
Hercules, CA, USA). Overnight cultures of transformants
were inoculated into LB medium containing 50 μg/mL of
antibiotic at 37°C and cultured until the OD600 reached 0.8.
Protein expression was induced by the addition of 1 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG), and growth
was continued for another 20 h at 18°C. Cells were har-
vested and resuspended to obtain a cell concentration
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containing 2% glucose, 50 μg/ mL of antibiotics, 1 mM
IPTG, and 1 mM PA in a test tube (14 mm × 145 mm) and
then cultured at 30°C for 8 h. The supernatant was
extracted twice using an equal volume of ethyl acetate, and
the upper aqueous phase was dried using a Speed Vac at
30°C, dissolved in 60 μL of dimethylsulfoxide (DMSO), and
analyzed using high-performance liquid chromatography
(HPLC). Because p-coumaroyl shikimate is not commer-
cially available, we used p-coumaric acid to generate a
standard curve for quantitative analysis of the reaction pro-
ducts. The UV spectra of p-coumaric acid are distinguish-
able from those of p-coumaroyl shikimate but they are very
similar and the absorption of the thioesters is usually
shifted to longer wavelength by a few nm. This is subtle
enough that it should be perfectly acceptable to use the free
acids as quantitation standards for the thioesters.
To determine the maximum conversion rate using the
optimized vector, protein expression was induced as
described above. The cell concentration was adjusted to an
OD600 of 3 in 25 mL of fresh M9 containing 2% glucose,
1 mM IPTG, and 50 μg/mL of antibiotics. The medium
was supplemented with 1 mM PA. The reaction product
(200 μL) was collected and extracted with ethyl acetate.
The supernatant was dried and dissolved with 100 μl of
dimethyl sulfoxide (DMSO). The sample was directly
injected to HPLC for analysis. The mean and the standard
error of the mean were calculated from triplicate experi-
ments. Analysis of variance (ANOVA) was carried out
using Tukey’s method with a significance level of P=0.01
using 2010 Microsoft Office Excel.
Production of chlorogenic acid in E. coli
The construct for the production of chlorogenic acid was
transformed into E. coli BL21(DE3) or BaroD cells. Induc-
tion of each construct was performed as described above.
To determine the optimal gene construct, 200 μM PA was
added to the growth medium.
To measure the production of chlorogenic acid in BaroD
cells harboring pC-EcycdiB and pC-NtHQT-Os4CL
(Table 1), the cell concentration was adjusted to an OD600
of 2.0, and CA was added to the medium to a final concen-
tration of 1.5 mM. Production of chlorogenic acid was peri-
odically monitored. The biotransformation was stopped by
boiling for 5 min and the biotransformation product was
centrifuged for 15 min at 13000 × g to remove the cell deb-
ris and other components prior to HPLC analysis. The
quantification of the product was carried out using a stand-
ard curve generated with authentic chlorogenic acid
(Sigma, MO, USA).
Analysis of the metabolites
The metabolites were analyzed using a Varian HPLC
equipped with a photo diode array (PDA) detector and aVarian C18 reversed-phase column (Varian, 4.60 × 250
mm, 3.5 μm particle size). The mobile phases consisted
of 0.1% formic acid in water and acetonitrile. For chloro-
genic acid, the program was: 20% acetonitrile at 0 min,
32% acetonitrile at 15 min, 90% acetonitrile at 17 min,
90% acetonitrile at 20 min, 20% acetonitrile at 21 min,
and 20% acetonitrile at 26 min. To analyze hydroxycin-
namoyl shikimate, the program was: 25% acetonitrile at
0 min, 40% acetonitrile at 10 min, 75% acetonitrile at 15
min, 90% acetonitrile at 22 min, 25% acetonitrile at 23
min, and 25% acetonitrile at 30 min. The flow rate was 1
mL/min, and the separation was monitored at 290 nm
and 320 nm.
The molecular masses of the metabolites were deter-
mined using a Varian 500-MS ion trap spectrometer.
Mass spectra were acquired simultaneously using an
electrospray ionization source in negative ionization
mode at 600 V. NMR spectrometry was done as
described before [35].Additional file
Additional file 1: Figure S1. The HMBC spectrum of the product P1.
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